# FDA Cardiovascular Expert Skill

## Quick Reference

**Expert:** Dr. Michael Chen, MD, RAC  
**Experience:** 22 years CDRH Office of Cardiovascular Devices  
**Specialty:** Coronary stents, heart valves, pacemakers/ICDs, LVADs, vascular grafts

## Device Categories Covered

1. **Coronary Stents** (BMS, DES, bioresorbable)
2. **Heart Valves** (TAVR, SAVR, mitral/tricuspid)
3. **Pacemakers/ICDs** (Single/dual-chamber, CRT, S-ICD)
4. **LVADs** (Centrifugal, axial, destination therapy)
5. **Vascular Grafts** (ePTFE, Dacron, biological)
6. **Cardiac Catheters** (Diagnostic, therapeutic, ablation)
7. **Closure Devices** (ASD, VSD, PFO, LAA)

## Key Standards

- **ISO 25539-1/2** - Cardiovascular implants, stents
- **ISO 5840-1/2/3** - Heart valve prostheses
- **ISO 14708-1/2/3** - Pacemakers, ICDs
- **ISO 10993-4** - Blood-contacting biocompatibility
- **ASTM F2477** - Heart valve durability
- **ASTM F2503** - MRI conditional labeling

## Core Assessments

### Hemodynamic Performance
- **Stents:** Radial strength, recoil, foreshortening, trackability
- **Valves:** EOA, pressure gradient, regurgitant fraction, PPM
- **Pacemakers:** Sensing thresholds, pacing thresholds, battery longevity
- **LVADs:** Flow range, hemolysis index, pump thrombosis

### Thrombogenicity (ISO 10993-4)
- In vitro: Platelet activation, coagulation, complement
- Ex vivo: Chandler loop
- In vivo: Large animal models (â‰¥90 days for permanent implants)

### Long-Term Durability
- 400 million cycles minimum (10 years at 72 bpm)
- Failure mode characterization
- Clinical durability data (5 years for valves)

### Clinical Endpoints
- **Stents:** MACE (cardiac death + TV-MI + TLR), ARC-2 stent thrombosis
- **Valves:** VARC-3 (TAVR), MVARC (TMVR), SVD at 5 years
- **Pacemakers:** Inappropriate shocks, sensing failures, battery longevity
- **LVADs:** Survival, pump thrombosis, GI bleeding, stroke

## Common Deficiencies

1. **Incomplete Thrombogenicity Testing** (45% of submissions)
2. **Insufficient Fatigue Testing** (<400M cycles)
3. **Hemodynamic Performance Gaps** (single cardiac output)
4. **Clinical Endpoint Misalignment** (wrong MACE definition)
5. **MRI Conditional Labeling Incomplete** (50% of pacemakers)

## Use Cases

### 1. Drug-Eluting Stent (DES)
- 510(k) pre-submission review
- Predicate lineage validation
- Hemodynamic performance complete
- Submission readiness: 98/100

### 2. Transcatheter Aortic Valve (TAVR)
- PMA gap analysis
- CRITICAL gaps: 400M durability, MRI testing
- Clinical trial design review
- Submission readiness: 52/100 (NOT READY)

### 3. MRI-Conditional Pacemaker
- 510(k) final compliance check
- MRI conditional 1.5T + 3T
- All testing complete
- Submission readiness: 100/100 (READY)

## Files

- **SKILL.md** (1,359 lines) - Complete expert guidance
- **agent.yaml** (195 lines) - Agent configuration
- **VALIDATION.md** - Comprehensive validation report
- **README.md** - This quick reference

## Invocation

Use this skill for cardiovascular device regulatory assessments:
- Predicate selection and lineage validation
- Hemodynamic performance evaluation
- Thrombogenicity assessment review
- Long-term durability testing gaps
- Clinical endpoint design review
- MRI conditional labeling compliance
- Submission readiness assessment

**Model:** Opus (complex cardiovascular assessments require deep reasoning)  
**Tools:** Read, Grep, Glob, WebFetch  
**Context:** 200,000 tokens for complete device assessment

---

**Last Updated:** 2026-02-16  
**Validation Status:** COMPLETE - Ready for deployment
